Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome

Clinical trial NCT00637221 · COMPLETED

Trial details

NCT number: NCT00637221
Sponsor: Neuropharm
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2008-03-01
Primary completion: 2008-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.